Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-07-02
1990-01-02
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514175, 514178, 514179, 540 15, 540 28, 540 41, 2603974, 26039745, A61K 3158, A61K 31585, A61K 3156, C07J 100
Patent
active
048913650
ABSTRACT:
17-Substituted estradienes and estratrienes of Formula I ##STR1## wherein ##STR2## R is alkyl, alkenyl or cycloalkyl of up to 5 carbon atoms if ##STR3## R is hydrogen, alkyl, alkenyl or cycloalkyl of up to 5 carbon atoms if ##STR4## is a CC-single or CC-double bond, exhibit, an aldosterone-antagonistic activity and a strong gestagen potency.
REFERENCES:
patent: 4536401 (1985-08-01), Neef et al.
patent: 4540686 (1985-09-01), Philibert et al.
Annen Klaus
Beier Sybille
Elger Walter
Laurent Henry
Nickisch Klaus
Lipovsky Joseph A.
Robinson Douglas W.
Schering Aktiengesellschaft
LandOfFree
17-Substituted estradienes and estratrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17-Substituted estradienes and estratrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17-Substituted estradienes and estratrienes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383825